Elin Danielsen Lunde1, Peter Brønnum Nielsen1,2, Sam Riahi1,3,4, Torben Bjerregaard Larsen1,2,4, Gregory Y H Lip2,5, Kirsten Fonager3,6, Mogens Lytken Larsen1,3,7, Albert Marni Joensen1,3,4. 1. a Department of Cardiology , Aalborg University Hospital , Aalborg , Denmark. 2. b Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health , Aalborg University , Aalborg , Denmark. 3. c Department of Clinical Medicine , Aalborg University , Aalborg , Denmark. 4. d Atrial Fibrillation Study Group , Aalborg University Hospital , Aalborg , Denmark. 5. e Institute of Cardiovascular Sciences , University of Birmingham , UK. 6. f Department of Social Medicine , Aalborg University Hospital , Aalborg , Denmark. 7. g Danish Centre of Inequality in Health, Department of Cardiology , Aalborg University Hospital , Aalborg , Denmark.
Abstract
BACKGROUND: Atrial fibrillation (AF) is a growing epidemic and evidence of a relationship to socioeconomic status (SES) is inconsistent. We aimed to summarize the literature about SES and AF and defined two objectives: (1) To examine the association between SES and the risk of AF; (2) To examine the association between SES and AF-related outcomes in an AF-population. METHODS: We performed a separate search for each objective in Ovid-MEDLINE and Ovid-Embase. For objective 1, the population included was healthy participants and outcome of interest was AF. For objective 2, the population included were patients with AF and outcome of interest was mortality, treatment, ablation for AF, knowledge about AF, and morbidity. RESULTS: For objective 1, 12 studies were included. No consistent pattern for an association between SES and the risk of AF was discovered. For objective 2, 39 studies comprising 42 outcomes were included. The majority of studies showed an association between low SES and increased mortality and morbidity. CONCLUSION: Low SES was associated with poorer outcomes when AF was present. These findings may imply that health-care professionals and policy interventions should focus on the promotion of AF-education and management among patients with AF and low SES.
BACKGROUND:Atrial fibrillation (AF) is a growing epidemic and evidence of a relationship to socioeconomic status (SES) is inconsistent. We aimed to summarize the literature about SES and AF and defined two objectives: (1) To examine the association between SES and the risk of AF; (2) To examine the association between SES and AF-related outcomes in an AF-population. METHODS: We performed a separate search for each objective in Ovid-MEDLINE and Ovid-Embase. For objective 1, the population included was healthy participants and outcome of interest was AF. For objective 2, the population included were patients with AF and outcome of interest was mortality, treatment, ablation for AF, knowledge about AF, and morbidity. RESULTS: For objective 1, 12 studies were included. No consistent pattern for an association between SES and the risk of AF was discovered. For objective 2, 39 studies comprising 42 outcomes were included. The majority of studies showed an association between low SES and increased mortality and morbidity. CONCLUSION: Low SES was associated with poorer outcomes when AF was present. These findings may imply that health-care professionals and policy interventions should focus on the promotion of AF-education and management among patients with AF and low SES.
Entities:
Keywords:
Atrial fibrillation; anticoagulation; drug therapy; morbidity; mortality; socioeconomic
Authors: Konsta Teppo; Jussi Jaakkola; Fausto Biancari; Olli Halminen; Miika Linna; Jari Haukka; Jukka Putaala; Paula Tiili; Ossi Lehtonen; Mikko Niemi; Pirjo Mustonen; Janne Kinnunen; Juha Hartikainen; K E Juhani Airaksinen; Mika Lehto Journal: Pharmacol Res Perspect Date: 2022-06
Authors: Frank Olsen; Bård Uleberg; Bjarne K Jacobsen; Ivar Heuch; Pål M Tande; Einar Bugge; Lise Balteskard Journal: BMC Public Health Date: 2022-02-14 Impact factor: 4.135
Authors: Katrin Kemp Gudmundsdottir; Anders Holmen; Tove Fredriksson; Emma Svennberg; Faris Al-Khalili; Johan Engdahl; Ulf Strömberg Journal: J Med Screen Date: 2020-03-30 Impact factor: 2.136